Skip to main content

Table 2 Baseline characteristics of participants in a randomized controlled study

From: Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Characteristics Educational lecture group Contact-based intervention group  
n = 56 n = 59 p
Gender, %female 41.1 42.4 0.89
Age, years: mean ± S.D. 36.8 ± 8.9 37.7 ± 10.0 0.82
Age group: %
 20–29 26.8 28.8 0.93
 30–39 37.5 32.2
 40–49 23.2 23.7
 50< 12.5 15.2
Pharmacist, years: mean ± S.D. 10.3 ± 6.9 11.9 ± 9.3 0.70
Psychiatric work experience, %positive 30.4 25.4 0.56
Experience of mental illness via a family member or close friend, %positive 32.1 32.2 0.99
Experience of schizophrenia via a family member or close friend, %positive 12.5 10.2 0.69
Frequency of medication counseling for schizophrenia patients, %positive
 Almost every day 0 1.7 0.37
 A few patients a week 12.5 11.9
 A few patients a month 42.9 39.0
 A few patients a year 21.4 32.2
 Nothing 23.2 15.3
SSCP, median (inter-quartile range) 74.0 (67.0–82.0) 71.0 (66.0–80.0) 0.276
Factor I, median (inter-quartile range) 32.0 (29.0–37.0) 31.0 (26.0–36.0) 0.242
Factor II, median (inter-quartile range) 20.0 (18.0–22.0) 20.0 (18.0–22.0) 0.840
Factor III, median (inter-quartile range) 12.0 (9.0–14.0) 11.0 (9.0–13.0) 0.336
Factor IV, median (inter-quartile range) 10.0 (9.0–11.8) 10.0 (8.0–12.0) 0.292
  1. Statistical analysis was performed using the chi-squared test or Mann-Whitney U test